Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform
Sana Biotechnology (SANA): Assessing Valuation After Strong Year-to-Date Share Price Gains [Yahoo! Finance]
Sana Biotechnology to Present at December 2025 Investor Conferences
Sana Biotechnology (NASDAQ:SANA) was downgraded by analysts at
Wall Stre
Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength [Yahoo! Finance]